Literature DB >> 21287412

An opinion and practice survey on the structure and management of data and safety monitoring boards.

Patti M Tereskerz1, Thomas M Guterbock, Deborah A Kermer, Jonathan D Moreno.   

Abstract

There is little to no empirical data available on how data and safety monitoring boards (DSMBs) are structured and how they operate. The purpose of this study was to provide data on this. To accomplish this goal, we administered a random survey on current structure and management practices and opinions as reported by principal investigators (PIs) and biostatisticians. We also surveyed Institutional Review Board (IRB) community members, as proxies for the public, as to their opinions on how DSMBs should be structured and managed. A final purpose was to compare opinions about what should be taking place to what is actually happening.

Entities:  

Mesh:

Year:  2011        PMID: 21287412     DOI: 10.1080/08989621.2011.542680

Source DB:  PubMed          Journal:  Account Res        ISSN: 0898-9621            Impact factor:   2.622


  4 in total

Review 1.  Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial's conduct and progress: a narrative review.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; Lehana Thabane
Journal:  Trials       Date:  2017-03-09       Impact factor: 2.279

2.  Survey of professional views on sharing interim results by the Data Safety Monitoring Board (DSMB): what to share, with whom and why.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; James Paul; Norman Buckley; Lehana Thabane
Journal:  Trials       Date:  2018-05-21       Impact factor: 2.279

3.  Exploring factors associated with views on sharing of certain interim trial result measures by the data safety monitoring board (DSMB) with non-DSMB members.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; James Paul; Norman Buckley; Lehana Thabane
Journal:  Trials       Date:  2018-11-12       Impact factor: 2.279

4.  The Essential Role of Data and Safety Monitoring Boards (DSMBs) in Ensuring the Ethics of Global Vaccine Trials to Address Coronavirus Disease 2019 (COVID-19O).

Authors:  Lisa Eckstein; Annette Rid; Dorcas Kamuya; Seema K Shah
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.